In the overall cohort, several factors were significantly associated with increased mortality, such as advancing age, lack of normalization of IGF1, higher IGF1 at diagnosis, higher GH concentrations at last control, the presence of diabetes mellitus, hypertension, cardiovascular events, and the absence of malignancy. This evidence concerns the gene IGF1 and Hypertension.